Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 2

From BugSigDB


Needs review

Curated date: 2024/11/15

Curator: Kavyaayala

Revision editor(s): Kavyaayala

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Epilepsy [X]Other epilepsy,[X]Other epilepsy (disorder),EF - Epileptic fit,EP - Epilepsy,Epilectic attack, NOS,EPILEP NEC W/O INTR EPIL,EPILEP NOS W/O INTR EPIL,epilepsy,Epilepsy (disorder),Epilepsy and recurrent seizures,EPILEPSY NEC W INTR EPIL,Epilepsy NOS,Epilepsy NOS (disorder),EPILEPSY NOS W INTR EPIL,Epilepsy, NOS,Epilepsy, unspecified,Epilepsy, unspecified, with intractable epilepsy,Epilepsy, unspecified, without mention of intractable epilepsy,Epileptic,Epileptic attack,Epileptic attack, NOS,Epileptic convulsions,Epileptic convulsions, NOS,Epileptic disorder,Epileptic disorder, NOS,Epileptic fit,Epileptic fits,Epileptic fits, NOS,Epileptic Seizure,Epileptic seizure (finding),Epileptic seizures,Epileptic seizures, NOS,Generalised convulsion,Generalised fit,Generalised seizure,Generalized convulsion,Generalized fit,Generalized seizure,Generalized seizure (finding),Other forms of epilepsy,Other forms of epilepsy (disorder),Other forms of epilepsy and recurrent seizures,Other forms of epilepsy NOS,Other forms of epilepsy NOS (disorder),Other forms of epilepsy, with intractable epilepsy,Other forms of epilepsy, without mention of intractable epilepsy,Seizure disorder,seizure disorder,Seizure disorder (disorder),Epilepsy
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
epileptic infants before treatment (P1)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Convulsion more than four times per week after treatment with ≥ 3 AEDs; no antibiotic exposure for at least 1 mo; no known genetic metabolic disorders or severe systemic illnesses
Group 0 sample size Number of subjects in the control (unexposed) group
30
Group 1 sample size Number of subjects in the case (exposed) group
14
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
Matched on Factors on which subjects have been matched on in a case-control study
age


Signature 1

Needs review

Curated date: 2024/11/16

Curator: Kavyaayala

Revision editor(s): Kavyaayala

Source: Supplementary Table 5

Description: Difference between the fecal microbiome of patients with refractory epilepsy before KD treatment (P1) vs healthy controls

Abundance in Group 1: increased abundance in epileptic infants before treatment (P1)

NCBI Quality ControlLinks
Acinetobacter
Bacillus
Butyricicoccus
Cronobacter
Dysgonomonas
Eggerthella
Enterococcus
Erysipelatoclostridium sp. An173
Gemella
Klebsiella
Lactococcus
Lactonifactor
Mogibacterium
Odoribacter
Peptoclostridium
Porphyromonas
Pseudomonas
Psychrobacter
Ralstonia
Streptococcus

Revision editor(s): Kavyaayala

Signature 2

Needs review

Curated date: 2024/11/16

Curator: Kavyaayala

Revision editor(s): Kavyaayala

Source: Supplementary Table 5

Description: Difference between the fecal microbiome of patients with refractory epilepsy before KD treatment (P1) vs healthy controls

Abundance in Group 1: decreased abundance in epileptic infants before treatment (P1)

NCBI Quality ControlLinks
Actinomyces
Atopobium
Bacteroides
Bifidobacterium
Bilophila
Clostridium
Escherichia
Granulicatella
Haemophilus

Revision editor(s): Kavyaayala